Detalhe da pesquisa
1.
Ruxolitinib as Salvage Therapy for Chronic Graft-versus-Host Disease.
Biol Blood Marrow Transplant
; 25(2): 265-269, 2019 02.
Artigo
em Inglês
| MEDLINE | ID: mdl-30201397
2.
Preoperative Panel Testing for Hereditary Cancer Syndromes Does Not Significantly Impact Time to Surgery for Newly Diagnosed Breast Cancer Patients Compared with BRCA1/2 Testing.
Ann Surg Oncol
; 24(10): 3055-3059, 2017 Oct.
Artigo
em Inglês
| MEDLINE | ID: mdl-28766202
3.
Somatic Tumor Profile Analysis in a Patient with Germline PMS2 Mutation and Synchronous Ovarian and Uterine Carcinomas.
J Pers Med
; 11(7)2021 Jul 05.
Artigo
em Inglês
| MEDLINE | ID: mdl-34357101
4.
Clinical interpretation and recommendations for patients with a variant of uncertain significance in BRCA1 or BRCA2: a survey of genetic counseling practice.
Genet Test
; 6(2): 107-13, 2002.
Artigo
em Inglês
| MEDLINE | ID: mdl-12215249
5.
Differences in physician referral practices and attitudes regarding hereditary breast cancer by clinical practice location.
Genet Med
; 5(5): 364-9, 2003.
Artigo
em Inglês
| MEDLINE | ID: mdl-14501831
6.
Breast cancer genetics education for college women: an evaluation of approaches.
J Cancer Educ
; 17(2): 74-7, 2002.
Artigo
em Inglês
| MEDLINE | ID: mdl-12092856